Patent · US Active

Method of reducing blood glucose by administering RON agonists

US10005848B2 · kind B2 · utility

0Cited by

2References

5Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Jackson Egen · South San Francisco, US
Jo-Anne Hongo · Redwood City, US
Steven Elliot Kauder · South San Francisco, US
Robert A. Lazarus · Millbrae, US
Lydia Santell · Foster City, US
Yan Wu · Foster City, US
Meredith Hazen · South San Francisco, US
Wei-Ching Liang · Foster City, US

Key dates

Filing date	May 29, 2015
Grant date	Jun 26, 2018
Priority date	—
Expiry date	May 29, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to RON compositions, in particular RON composition comprising a RON agonist, and methods of using the compositions for the treatment of diseases. The invention also relates to diagnosis of RON-associated or MSP-associated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.